Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - Boston Therapeutics, Inc. | a50143619-ex991.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
January
24, 2012
Date
of Report (Date of earliest event reported)
BOSTON
THERAPEUTICS, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
333-164785 |
27-0801073 |
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
33 South Commercial Street, Manchester, NH 03101
(Address
of principal executive offices) (Zip Code)
(978) 886-0421
(Registrant’s
telephone number, including area code)
(Former Name or
Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On January 24, 2012, Boston Therapeutics, Inc. (the “Company”) announced the results of clinical trials of SUGARDOWN®, a non-systemic dietary supplement designed to reduce post-meal elevation of blood glucose, performed on healthy volunteers at the University of Sydney .
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BOSTON THERAPEUTICS, INC. |
|||
|
|||
Date: | January 24, 2012 | By: |
/s/ David Platt, Ph.D. |
David Platt |
|||
Chief Executive Officer |
Exhibit Index
Exhibit No. |
Description |
|||
99.1 |
Press Release dated January 24, 2012 |